MedAware
Medication safety monitoring platform that uses machine learning and outlier detection to flag patient- and provider-specific medication risks.
Last updated: June 5, 2026
Back to directoryAI-powered pharmacovigilance signal detection product from RxLogix for identifying, validating, and managing drug safety signals across data sources.
Life sciences organizations that need signal lifecycle management across literature, FAERS, VigiBase, EVDAS, real-world data, and internal safety systems.
Compare within workflow: Medication safety and dosing · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating RxLogix PV Signal as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat as regulated life-sciences pharmacovigilance infrastructure; validate against GxP, FDA, EMA, local authority, SOP, inspection, and safety reporting requirements before production use. |
|---|---|
| Privacy | Review safety case data, adverse-event narratives, patient identifiers, reporter information, literature and database connectors, role access, audit logs, hosting model, and cross-border processing. |
| Evidence | Evaluate signal detection sensitivity, false positives, literature mining quality, data-source coverage, validation workflow, audit evidence, and safety physician acceptance before relying on automation. |
| Workflow | Best governed as a PV operations platform with safety expert review, SOP-aligned signal lifecycle states, documented decisions, inspection-ready audit trails, and periodic model and data-source review. |
RxLogix describes PV Signal as an AI-powered pharmacovigilance signal product using AI, NLP, literature mining, global safety databases, and real-world data for signal detection and workflow automation; platform materials describe cloud-native PV lifecycle coverage, GxP/HIPAA/FDA/EMA support, audit tools, integrations, and enterprise pharmacovigilance adoption.
Not for: Provider prescribing decisions, standalone safety conclusions without qualified PV review, or use without validated SOPs, audit controls, and regulatory accountability.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.